Monday, June 6, 2011

Arstasis Scores $25.5M

Redwood City-based Arstasis, a developer of surgical tools for femoral artery access, recently raised $25.5M in a Series E funding round. Names of the investors in the firm were not disclosed. The firm said recently that the funding will go towards working capital and the launch of its AXERA Access Device. More information »